S. K. Anderson

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

Bret B. Friday, S. K. Anderson, J. Buckner et al. · Neuro-Oncology · 2011 · 210 citations · Full text

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases

Kurt A. Jaeckle, Jesse G. Dixon, S. K. Anderson et al. · Cancer Medicine · 2020 · 24 citations · Full text

Ongoing Clinical Trials

Joanna Clarke, Marguerite Ennis, Kathleen R. Lamborn et al. · Neuro-Oncology · 2010 · 22 citations · Full text

Clinical Trial Management, Clinical Endpoint, Clinical Trials +5

Cardiovascular responses in black and white males during exercise

Michael J. Berry, Timothy J. Zehnder, C. B. Berry et al. · Journal of Applied Physiology · 1993 · 12 citations

Physical Activity, Cardiovascular Responses, Cardiovascular Function +19

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Kurt A. Jaeckle, S. K. Anderson, Erin Twohy et al. · Journal of Neuro-Oncology · 2019 · 10 citations · Full text

Phase I-ii Trial, Recurrent Oligodendroglioma, Tumoral Pathology +8